BerganKDV Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

BerganKDV Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-400	Closed	-$31K	–	1109
2020 Q1	$31K	Buy	+400	New	+$35.4K	0.01%	375

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BerganKDV Wealth Management's XBI Position: Q2 2020 in Review

BerganKDV Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2020, closing a stake of 400 shares — an estimated $31K sold.

BerganKDV Wealth Management first reported a position in XBI in Q1 2020 and held it in 1 quarter. The position peaked at $31K in Q1 2020. 525 funds tracked by Wall St. Rank hold XBI as of Q2 2020.

BerganKDV Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2020 after selling out during the quarter.
BerganKDV Wealth Management sold 400 State Street SPDR S&P Biotech ETF shares in Q2 2020, an estimated $31K.
BerganKDV Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and held it in 1 quarter.
BerganKDV Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $31K in Q1 2020.
525 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2020.

Based on BerganKDV Wealth Management's 13F filing for Q2 2020, filed 13 Aug 2020.